紫杉醇药物洗脱支架在冠心病介入治疗中的研究进展(4)
 |
| 第1页 |
参见附件(2663KB，5页)。
[28] Hong MK，Mintz GS，Lee CW.In-stent restenosis treated with stent-based delivery of paclitaxel incorporated in a slow-release polymer formulation[J].Circulation,2003,107:559-564.
[29] Gershlick A,De Scheerder I,Chevalier B,et al.Inhibition of restenosis with a paclitaxel-eluting，polymer-free coronary stent:The European evaluation of paclitaxel Eluting Stent(ELUTES) trial[J].Circulation,2004,109:487-493.
[30] Virmani R，Liistro F，Stankovic G，et al.Mechanism of late instent restenosis after implantation of a paclitaxel derivate-eluting polymer stent system in humans[J].Circulation，2002,106(21):2649-2651.
[31] Galli M，Bartorelli A，Bedogni F，et al.Italian BiodivYsio open registry(BiodivYsio PC-coated stent):Study of clinical outcomes of the implant of a PC-coated coronary stent[J].J Invasive Cardiology，2000,12(9):452-458.
[32] 李虎,王海昌,郭文怡,等.紫杉醇慢速释放支架TAXUS【sup】TM【/sup】临床应用及6个月随访[J].中国介入心脏病学杂志,2004,12(5):11-13.
[33] Carter AJ,Aggarwal M,Kopia GA,et al.Long-time effects of polymer-based,slow-release,sirolimus-eluting stents in a porcine coronary model[J].Cardiovasc Res,2004,63(4):617-624.
[34] Togni M,Windecker S,Cocchia R,et al.Sirolimus-eluting stents associated with paradoxic coronary vasoconstriction[J].J Am Coll Cardiol,2005,46(2):231-236.
[35] Togni M,Raber L,Cocchia R,et al.Local vascular dysfunction after coronary paclitaxel-eluting stent implantation[J].Int J Cardiol,2006,120(2):212-220.
[36] Waksman R,Buch AN,Torguson R,et al.Long-term clinical outcomes and thrombosis rates of Sirolimus-Eluting versus Paclitaxel-eluting stents in an unselected population with coronary artery disease(REWARDS registry)[J].Am J Cardiol,2007,100(1):45-51.
作者简介：谢勉(1984—)，男，现为天津中医药大学2008级中西医结合专业在读硕士研究生(邮编：300073)；党群(通讯作者)，工作于南开医院(邮编：300100)。
(收稿日期：2010-12-25)
(本文编辑 郭怀印)
您现在查看是摘要介绍页，详见PDF附件(2663KB，5页)。